Avasimibe

阿伐麦布

Report date: 2022/01/14 13:23:58

NME

Base Information

Drug NameAvasimibe

Drug Alias NameCI-1011CI 1011

ClassificationSmall molecules > Heterocyclic drugs

Mechanisms of ActionAcyl coenzyme A:cholesterol acyltransferase inhibitors

TargetsAcyl coenzyme A:cholesterol acyltransferase

Therapy Area/IndicationsHyperlipidemiasAtherosclerosis

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryN/A

CombinationsNo

Global Highest StatusDiscontinued (Phase 3 Clinical)

Highest Status in ChinaN/A

Originator CompaniesPfizer Inc

China Registration ClassN/A

Active CompaniesN/A

Inactive CompaniesPfizer Inc

Active IndicationsN/A

Inactive IndicationsHyperlipidemiasAtherosclerosis

ATC CodeN/A